Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

SCRX

Sciele Pharma (MM) (SCRX)

Sciele Pharma (MM)
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:SCRX
일자시간출처헤드라인심볼기업
2021/08/2602:00Business WiretheScore Bet Becomes Official Gaming Partner of Golf Canada and its Marquee Golf Championships, the RBC Canadian Open and CP Women’s OpenNASDAQ:SCRXSciele Pharma (MM)
2021/08/1923:00Business WiretheScore Selects Toronto’s Waterfront Innovation Centre as Site for New, Expansive HeadquartersNASDAQ:SCRXSciele Pharma (MM)
2021/08/0520:01Business WirePenn National Gaming to Acquire Score Media and Gaming, Creating North America’s Leading Digital Sports Content, Gaming and Technology CompanyNASDAQ:SCRXSciele Pharma (MM)
2021/07/1406:01Business WiretheScore Reports F2021 Q3 Financial ResultsNASDAQ:SCRXSciele Pharma (MM)
2021/07/0620:30Business WiretheScore to Report Q3 F2021 Financial Results on Tuesday, July 13, 2021NASDAQ:SCRXSciele Pharma (MM)
2021/06/2305:16Business WiretheScore Applauds Passage by the Senate of Historic Legislation to Legalize Single Event Sports Betting in CanadaNASDAQ:SCRXSciele Pharma (MM)
2021/04/2308:41Business WiretheScore Issues Statement Following the Passing of Bill C-218 by the House of CommonsNASDAQ:SCRXSciele Pharma (MM)
2021/04/1406:02Business WiretheScore Reports Record F2021 Q2 Financial ResultsNASDAQ:SCRXSciele Pharma (MM)
2021/04/0620:45Business WiretheScore To Report Q2 F2021 Financial Results on Tuesday, April 13, 2021NASDAQ:SCRXSciele Pharma (MM)
2021/03/3102:02Business WirePGA TOUR Announces theScore Bet as an Official Betting OperatorNASDAQ:SCRXSciele Pharma (MM)
2021/03/2921:30Business WiretheScore Secures Market Access for Mobile Sports Betting in Illinois Through Agreement with Caesars EntertainmentNASDAQ:SCRXSciele Pharma (MM)
2021/03/0201:04Business WiretheScore Announces Closing of US$186.3 Million Initial Public Offering in the United StatesNASDAQ:SCRXSciele Pharma (MM)
2008/10/1006:01Business WireShionogi Completes Acquisition of ScieleNASDAQ:SCRXSciele Pharma (MM)
2008/10/1000:10Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:SCRXSciele Pharma (MM)
2008/10/0921:02Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:SCRXSciele Pharma (MM)
2008/10/0920:30Business WireShionogi and Sciele Announce Completion of Subsequent Offering PeriodNASDAQ:SCRXSciele Pharma (MM)
2008/10/0622:54Edgar (US Regulatory)Sciele Pharma, Inc. - Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:SCRXSciele Pharma (MM)
2008/10/0619:30Business WireShionogi and Sciele Announce Successful Tender Offer and Commencement of Subsequent OfferingNASDAQ:SCRXSciele Pharma (MM)
2008/10/0619:05Edgar (US Regulatory)Sciele Pharma, Inc. - Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:SCRXSciele Pharma (MM)
2008/10/0122:45Edgar (US Regulatory)Sciele Pharma, Inc. - Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:SCRXSciele Pharma (MM)
2008/09/2608:38PR Newswire (US)Standard & Poor's Announces Update to the U.S. Market Cap Guidelines and Changes to U.S. IndicesNASDAQ:SCRXSciele Pharma (MM)
2008/09/1922:44Edgar (US Regulatory)Sciele Pharma, Inc. - Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:SCRXSciele Pharma (MM)
2008/09/1919:08Edgar (US Regulatory)Sciele Pharma, Inc. - Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:SCRXSciele Pharma (MM)
2008/09/1919:00Business WireShionogi and Sciele Announce Receipt of United States Antitrust ClearanceNASDAQ:SCRXSciele Pharma (MM)
2008/09/1622:46Business WireSciele Completes Pivotal Phase III Program for Glycopyrrolate in Pediatric Patients with Chronic, Moderate-to-Severe DroolingNASDAQ:SCRXSciele Pharma (MM)
2008/09/0900:19Edgar (US Regulatory)Sciele Pharma, Inc. - Statement of Ownership: Solicitation (SC 14D9)NASDAQ:SCRXSciele Pharma (MM)
2008/09/0900:03Edgar (US Regulatory)Sciele Pharma, Inc. - Tender offer statement by Third Party (SC TO-T)NASDAQ:SCRXSciele Pharma (MM)
2008/09/0405:49Edgar (US Regulatory)Sciele Pharma, Inc. - Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:SCRXSciele Pharma (MM)
2008/09/0405:47Edgar (US Regulatory)Sciele Pharma, Inc. - Current report filing (8-K)NASDAQ:SCRXSciele Pharma (MM)
2008/09/0305:58Edgar (US Regulatory)Sciele Pharma, Inc. - Statement of Ownership: Solicitation (SC 14D9)NASDAQ:SCRXSciele Pharma (MM)
 검색 관련기사 보기:NASDAQ:SCRX